BP000323-PRO-294: Recombinant Human CD99 Antigen (CD99) Protein
Source: E. coli-derived.
Applications: ELISA; Inhibition Assays; WB.BP000394-CMV-211: Recombinant CMV gB
Source: The E.Coli-derived.
Purity > 95%, by 10% PAGE and RP-HPLC.
Applications: ELISA, WB.BP000394-CMV-212: Recombinant CMV Pp28 (UL99)
Source: The E.Coli-derived.
Purity > 95%, by 10% PAGE.
Applications: ELISA, WB.BP000394-CMV-213: Recombinant CMV Pp38 (UL80a)
Source: The E.Coli-derived.
Purity > 95%, by 10% PAGE.
Applications: ELISA, WB.BP000394-CMV-214: Recombinant CMV Pp52 (UL44)
Source: The E.Coli-derived.
Purity > 95%, by 10% PAGE.
Applications: ELISA, WB.BP000489-PRO-059: Bovine Fibronectin Protein
Source: Bovine Plasma-derived.
Purity: > 95% by SDS-PAGE.BP000489-PRO-131: Rat Fibronectin Protein
Source: Rat Plasma-derived.
Purity: > 95% by SDS-PAGE.BP000489-PRO-448: Human Fibronectin Protein
Source: Human Plasma-derived.
Purity: > 95% by SDS-PAGE.BP000597-PKA-230: Recombinant Human FGFR1 Fc Chimera
Source: Insect Cells-derived.
Determined by its ability to inhibit human FGF acidic-dependent proliferation on R1 cells. The ED50 for this effect is typically at 15.0-30.0 ng/ml.
Purity > 90%, by RP-HPLC and SDS-PAGE.BP000598-PKA-231: Recombinant Human FGFR2 Fc Chimera
Source: Insect Cells-derived.
The ED50 for this effect is typically at 15.0-30.0 ng/ml.
Purity > 90%, by RP-HPLC and SDS-PAGE.